Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200331165> ?p ?o ?g. }
- W4200331165 abstract "Objective: Abnormal lipid metabolism has a close link to the pathophysiology of schizophrenia (SZ). This study mainly aimed to evaluate the association of variants at apolipoprotein A1 (APOA1) and APOA4 with SZ in a Chinese Han population. Methods: The rs5072 of APOA1 and rs1268354 of APOA4 were examined in a case-control study involving 2,680 patients with SZ from the hospital and 2,223 healthy controls screened by physical examination from the community population. The association was estimated with the odds ratio (OR) and 95% confidence intervals (95% CIs) by logistic regression. The APOA1 and APOA4 messenger RNA (mRNA) in peripheral blood leukocytes were measured by real-time PCR and compared between SZ cases and controls. Serum apoA1 levels were detected by turbidimetric inhibition immunoassay and high-density lipoprotein cholesterol (HDL-C) levels were detected by the homogeneous method. Results: Both of the rs5072 of APOA1 and rs1268354 of APOA4 had statistically significant associations with SZ. After adjustment for age and sex, ORs (95% CIs) of the additive model of rs5072 and rs1268354 were 0.82 (0.75-0.90) and 1.120 (1.03-1.23), and p-values were 3.22 × 10-5 and 0.011, respectively. The association of rs5072 with SZ still presented statistical significance even after Bonferroni correction (p-value×6). SZ patients during the episode presented lower levels of apoA1, HDL-C, mRNA of APOA1 common variants and transcript variant 4, and APOA4 mRNA than controls (p < 0.01) while SZ patients in remission showed a significantly decreased APOA1 transcript variant 3 expression level and increased APOA4 mRNA expression level (p < 0.01). mRNA expression levels of APOA1 transcript variant 4 significantly increased with the variations of rs5072 in SZ during the episode (ptrend = 0.017). After the SZ patients received an average of 27.50 ± 9.90 days of antipsychotic treatment, the median (interquartile) of serum apoA1 in the SZ episode significantly increased from 1.03 (1.00.1.20) g/L to 1.08 (1.00.1.22) g/L with the p-value of 0.044. Conclusion: Our findings suggest that the genetic variations of APOA1 rs5072 and APOA4 rs1268354 contribute to the susceptibility of SZ, and the expression levels of APOA1 and APOA4 mRNA of peripheral blood leukocytes decreased in SZ patients during the episode while APOA4 increased after antipsychotic treatment." @default.
- W4200331165 created "2021-12-31" @default.
- W4200331165 creator A5015598217 @default.
- W4200331165 creator A5022767802 @default.
- W4200331165 creator A5027748236 @default.
- W4200331165 creator A5039263801 @default.
- W4200331165 creator A5048681682 @default.
- W4200331165 creator A5056995940 @default.
- W4200331165 creator A5064020010 @default.
- W4200331165 creator A5078734134 @default.
- W4200331165 date "2021-12-06" @default.
- W4200331165 modified "2023-09-30" @default.
- W4200331165 title "The Variants at APOA1 and APOA4 Contribute to the Susceptibility of Schizophrenia With Inhibiting mRNA Expression in Peripheral Blood Leukocytes" @default.
- W4200331165 cites W1965861718 @default.
- W4200331165 cites W1975909066 @default.
- W4200331165 cites W1981720975 @default.
- W4200331165 cites W1986439388 @default.
- W4200331165 cites W1992518463 @default.
- W4200331165 cites W2000744762 @default.
- W4200331165 cites W2005031405 @default.
- W4200331165 cites W2010342644 @default.
- W4200331165 cites W2016854825 @default.
- W4200331165 cites W2030588736 @default.
- W4200331165 cites W2031254500 @default.
- W4200331165 cites W2031400933 @default.
- W4200331165 cites W2036629979 @default.
- W4200331165 cites W2047361818 @default.
- W4200331165 cites W2049825478 @default.
- W4200331165 cites W2059948137 @default.
- W4200331165 cites W2070654483 @default.
- W4200331165 cites W2074890254 @default.
- W4200331165 cites W2077524341 @default.
- W4200331165 cites W2090454074 @default.
- W4200331165 cites W2105527159 @default.
- W4200331165 cites W2126180792 @default.
- W4200331165 cites W2147024435 @default.
- W4200331165 cites W2147359941 @default.
- W4200331165 cites W2148602524 @default.
- W4200331165 cites W2157738629 @default.
- W4200331165 cites W2166739899 @default.
- W4200331165 cites W2606928194 @default.
- W4200331165 cites W2616325230 @default.
- W4200331165 cites W2801704870 @default.
- W4200331165 cites W2916226351 @default.
- W4200331165 cites W2950709739 @default.
- W4200331165 cites W2954898577 @default.
- W4200331165 cites W3135384619 @default.
- W4200331165 cites W3173578818 @default.
- W4200331165 cites W3183861008 @default.
- W4200331165 cites W3197041122 @default.
- W4200331165 cites W4211145950 @default.
- W4200331165 cites W4230482815 @default.
- W4200331165 cites W4252221343 @default.
- W4200331165 doi "https://doi.org/10.3389/fmolb.2021.785445" @default.
- W4200331165 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34938775" @default.
- W4200331165 hasPublicationYear "2021" @default.
- W4200331165 type Work @default.
- W4200331165 citedByCount "1" @default.
- W4200331165 countsByYear W42003311652023 @default.
- W4200331165 crossrefType "journal-article" @default.
- W4200331165 hasAuthorship W4200331165A5015598217 @default.
- W4200331165 hasAuthorship W4200331165A5022767802 @default.
- W4200331165 hasAuthorship W4200331165A5027748236 @default.
- W4200331165 hasAuthorship W4200331165A5039263801 @default.
- W4200331165 hasAuthorship W4200331165A5048681682 @default.
- W4200331165 hasAuthorship W4200331165A5056995940 @default.
- W4200331165 hasAuthorship W4200331165A5064020010 @default.
- W4200331165 hasAuthorship W4200331165A5078734134 @default.
- W4200331165 hasBestOaLocation W42003311651 @default.
- W4200331165 hasConcept C104317684 @default.
- W4200331165 hasConcept C105580179 @default.
- W4200331165 hasConcept C105795698 @default.
- W4200331165 hasConcept C118552586 @default.
- W4200331165 hasConcept C126322002 @default.
- W4200331165 hasConcept C127808970 @default.
- W4200331165 hasConcept C134018914 @default.
- W4200331165 hasConcept C151956035 @default.
- W4200331165 hasConcept C156957248 @default.
- W4200331165 hasConcept C185592680 @default.
- W4200331165 hasConcept C2776412080 @default.
- W4200331165 hasConcept C2778163477 @default.
- W4200331165 hasConcept C2780745583 @default.
- W4200331165 hasConcept C2908647359 @default.
- W4200331165 hasConcept C33923547 @default.
- W4200331165 hasConcept C44249647 @default.
- W4200331165 hasConcept C54355233 @default.
- W4200331165 hasConcept C62746215 @default.
- W4200331165 hasConcept C71924100 @default.
- W4200331165 hasConcept C86803240 @default.
- W4200331165 hasConcept C99454951 @default.
- W4200331165 hasConceptScore W4200331165C104317684 @default.
- W4200331165 hasConceptScore W4200331165C105580179 @default.
- W4200331165 hasConceptScore W4200331165C105795698 @default.
- W4200331165 hasConceptScore W4200331165C118552586 @default.
- W4200331165 hasConceptScore W4200331165C126322002 @default.
- W4200331165 hasConceptScore W4200331165C127808970 @default.
- W4200331165 hasConceptScore W4200331165C134018914 @default.
- W4200331165 hasConceptScore W4200331165C151956035 @default.
- W4200331165 hasConceptScore W4200331165C156957248 @default.
- W4200331165 hasConceptScore W4200331165C185592680 @default.